G. Walmsley Graham, Director at Olema Pharmaceuticals, Inc. (OLMA), bought 700,761 shares at $6.75 ($4.7M) on 2024-12-17, disclosed to the SEC on 2024-12-17.
Scheduled purchase ($4.7M) by Director.
Something here stands out, but not much.
| Filing → |
| OLMA | BUY | 2024-12-18 | $9.5M | — | Filing → |
| OLMA | SELL | 2024-12-18 | $9.5M | — | Filing → |
| OLMA | SELL | 2024-06-06 | $17.4M | — | Filing → |